Ad is loading...
OALVX
Price
$20.65
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
VVIAX
Price
$69.72
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
Ad is loading...

OALVX vs VVIAX

Header iconOALVX vs VVIAX Comparison
Open Charts OALVX vs VVIAXBanner chart's image
Optimum Large Cap Value A
Price$20.65
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index Adm
Price$69.72
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
OALVX vs VVIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
OALVX vs. VVIAX commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OALVX is a Buy and VVIAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 184B vs. OALVX (1.91B). VVIAX pays higher dividends than OALVX: VVIAX (2.36) vs OALVX (1.33). OALVX was incepted earlier than VVIAX: OALVX (21 years) vs VVIAX (24 years). OALVX is a more actively managed with annual turnover of: 22.00 vs. VVIAX (10.00). OALVX has a lower initial minimum investment than VVIAX: OALVX (1000) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 26.09 vs. OALVX (8.89). VVIAX return over 5 years is better than : 53.09 vs. OALVX (24.87).
OALVXVVIAXOALVX / VVIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence21 years24 years-
Gain YTD18.95219.67296%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets1.91B184B1%
Annual Yield % from dividends1.332.3657%
Returns for 1 year8.8926.0934%
Returns for 3 years-3.1224.77-13%
Returns for 5 years24.8753.0947%
Returns for 10 years39.62112.2635%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DOLE15.260.19
+1.26%
Dole plc
NCNO40.450.37
+0.92%
nCino
SGHT3.760.03
+0.80%
Sight Sciences
VICI32.370.25
+0.78%
VICI Properties
SABS3.070.01
+0.33%
SAB Biotherapeutics